Lipocine Inc. (LPCN)

NASDAQ

$2.96

$+0.70

(+33.33%)

Pre-Market

Lipocine Inc. (LPCN) Live Price Chart

Last updated: ⁦2026-10-07 13:14:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Lipocine Inc. (LPCN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.96, with a market capitalization of $17.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.81 to $12.37. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$17.07M
Open	$2.10
Day's High	$326.91
Day's Low	$1.81
Previous Close	$2.10
Volume	72.13M
Average Volume	35.43K
P/E Ratio	--
52-Week High	$12.37
52-Week Low	$1.81
Dividend Yield	--
Earnings Date	--

Lipocine Inc. (LPCN) Pre-Market Stock Price

Lipocine Inc. (LPCN) is trading at $2.94 in pre-market trading as of 2026-10-07 12:58:53, up 40.14% ($0.84) from the previous close of $2.10

Pre-market trading shows how investors are pricing LPCN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Lipocine Inc. (LPCN) 7-Day Stock Price Change

Over the past seven days, Lipocine Inc. (LPCN) moved from $2.09 to $2.96, representing a gain of 41.48% ($0.87).

The stock traded between $2.05 and $3.93 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 33.25 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

LPCN 52-Week Price Position

Position in Range: 10.9%

52W Low$1.81

52W High$12.37

LPCN is currently trading at $2.96, placing it 10.9% of the way from its 52-week low of $1.81 to its 52-week high of $12.37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lipocine Inc. (LPCN)?

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Lipocine Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	14
Exchange	NASDAQ
Company Website	https://www.lipocine.com

How to Buy Lipocine Inc. (LPCN) Stock on MEXC

Eligible investors can buy real shares of Lipocine Inc. (LPCN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LPCN and Place Your Order

Open the RealStocks trading page and search for LPCN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lipocine Inc. (LPCN) stock price today?

Lipocine Inc. (LPCN) is currently trading at $ 2.96, up 40.81% ($0.86) from the previous close of $ 2.10. Intraday prices update in real time during regular trading hours.

2.Is LPCN stock going up or down today?

As of 2026-10-07 12:58:53, LPCN is trading at $ 2.96, up 40.81% ($0.86) from its previous close of $ 2.10. The stock has traded between $ 1.81 and $ 326.91 during today’s regular session. Past price movements do not guarantee future results.

3.What is LPCN pre-market price?

As of 2026-10-07 12:58:53, LPCN is trading at $ 2.94 in pre-market trading, up 40.14% ($0.84) from the previous close of $ 2.10. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LPCN after-hours price?

As of 2026-10-07 12:58:53, LPCN is trading at $ 2.10 in after-hours trading, down 0.24% ($0.00) from the regular-session close of $ 2.10. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LPCN stock trading now?

LPCN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LPCN sit relative to its 52-week high and low?

Over the past 52 weeks, LPCN has traded between a low of $ 1.81 and a high of $ 12.37. At $ 2.96, the stock is positioned 10.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lipocine Inc. in?

Lipocine Inc. (LPCN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lipocine Inc.'s market capitalization and where is it listed?

Lipocine Inc. is listed on the NASDAQ exchange with a market capitalization of $ 17.07M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LPCN valued in terms of P/E ratio and EPS?

LPCN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.44. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lipocine Inc. pay a dividend?

Lipocine Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.